Your browser doesn't support javascript.
loading
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes.
Simpson, Eric; Armstrong, April; Boguniewicz, Mark; Chiesa Fuxench, Zelma C; Feely, Meghan; Pierce, Evangeline; Sun, Luna; Chen, Yun-Fei; Angle, Robinette; Silverberg, Jonathan I.
Affiliation
  • Simpson E; Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA.
  • Armstrong A; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Boguniewicz M; Division of Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, USA.
  • Chiesa Fuxench ZC; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Feely M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Pierce E; Department of Dermatology, Mount Sinai Health System, New York, New York, USA.
  • Sun L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Chen YF; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Angle R; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Silverberg JI; Eli Lilly and Company, Indianapolis, Indiana, USA.
Dermatol Ther ; 35(12): e15954, 2022 12.
Article in En | MEDLINE | ID: mdl-36270978
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos